David Coman is a seasoned executive with extensive experience in leadership roles within the biopharmaceutical and telecommunications industries. Currently serving as Chief Executive Officer at BGB Group since November 2024, Coman previously held the same title at Science 37 from November 2019 to November 2024. Prior roles include Chief Strategy Officer & General Manager at ERT, where enterprise strategy and corporate development nearly doubled revenue, and Chief Marketing Officer at IQVIA, contributing to the development of top-selling drugs. Coman's background includes significant marketing leadership positions at Orchestria, IMS Health, Talk America, Excel Communications, and Aerial Communications, demonstrating a track record of driving growth and strategic initiatives. Coman holds an MBA from Northwestern University's Kellogg School of Management and a BA in Advertising from Michigan State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices